Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Defining The Next Generation Of Coronavirus Stocks: This Company Comes into Focus

Revive Therapeutics Ltd. (OTC: RVVTF) (CSE: RVV): Management Believes That The Company…